Arkolith/Insider Trading/DMTK/Form 4

Dobak John

Chief Executive Officer, DirectorDermTech, Inc. (DMTK) · full profile →Form 4 · filed Mar 9, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$97K
Net Open-Market Flow
-$97K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2023Sell(S)709$4.06$3K667K
Mar 7, 2023Sell(S)23K$4.06$94K644K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-017692) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML